Literature DB >> 22961720

Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents.

S E McCormack1, O Shaham, M A McCarthy, A A Deik, T J Wang, R E Gerszten, C B Clish, V K Mootha, S K Grinspoon, A Fleischman.   

Abstract

UNLABELLED: What is already known about this subject Circulating concentrations of branched-chain amino acids (BCAAs) can affect carbohydrate metabolism in skeletal muscle, and therefore may alter insulin sensitivity. BCAAs are elevated in adults with diet-induced obesity, and are associated with their future risk of type 2 diabetes even after accounting for baseline clinical risk factors. What this study adds Increased concentrations of BCAAs are already present in young obese children and their metabolomic profiles are consistent with increased BCAA catabolism. Elevations in BCAAs in children are positively associated with insulin resistance measured 18 months later, independent of their initial body mass index.
BACKGROUND: Branched-chain amino acid (BCAA) concentrations are elevated in response to overnutrition, and can affect both insulin sensitivity and secretion. Alterations in their metabolism may therefore play a role in the early pathogenesis of type 2 diabetes in overweight children.
OBJECTIVE: To determine whether paediatric obesity is associated with elevations in fasting circulating concentrations of BCAAs (isoleucine, leucine and valine), and whether these elevations predict future insulin resistance.
METHODS: Sixty-nine healthy subjects, ages 8-18 years, were enrolled as a cross-sectional cohort. A subset of subjects who were pre- or early-pubertal, ages 8-13 years, were enrolled in a prospective longitudinal cohort for 18 months (n = 17 with complete data).
RESULTS: Elevations in the concentrations of BCAAs were significantly associated with body mass index (BMI) Z-score (Spearman's Rho 0.27, P = 0.03) in the cross-sectional cohort. In the subset of subjects that followed longitudinally, baseline BCAA concentrations were positively associated with homeostasis model assessment for insulin resistance measured 18 months later after controlling for baseline clinical factors including BMI Z-score, sex and pubertal stage (P = 0.046).
CONCLUSIONS: Elevations in the concentrations of circulating BCAAs are significantly associated with obesity in children and adolescents, and may independently predict future insulin resistance.
© 2012 The Authors. Pediatric Obesity © 2012 International Association for the Study of Obesity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22961720      PMCID: PMC3519972          DOI: 10.1111/j.2047-6310.2012.00087.x

Source DB:  PubMed          Journal:  Pediatr Obes        ISSN: 2047-6302            Impact factor:   4.000


  45 in total

1.  Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents.

Authors:  Neslihan Gungor; Rola Saad; Janine Janosky; Silva Arslanian
Journal:  J Pediatr       Date:  2004-01       Impact factor: 4.406

2.  Oxidation of branched chain amino acids by isolated hearts and diaphragms of the rat. The effect of fatty acids, glucose, and pyruvate respiration.

Authors:  M G Buse; J F Biggers; K H Friderici; J F Buse
Journal:  J Biol Chem       Date:  1972-12-25       Impact factor: 5.157

3.  Plasma amino acid levels and insulin secretion in obesity.

Authors:  P Felig; E Marliss; G F Cahill
Journal:  N Engl J Med       Date:  1969-10-09       Impact factor: 91.245

4.  Effect of 24 hour fast in obese children.

Authors:  J L Chaussain; P Georges; G Olive; J C Job
Journal:  Biomedicine       Date:  1976-09-30

5.  Mechanism of amino acid-induced skeletal muscle insulin resistance in humans.

Authors:  Michael Krebs; Martin Krssak; Elisabeth Bernroider; Christian Anderwald; Attila Brehm; Martin Meyerspeer; Peter Nowotny; Erich Roth; Werner Waldhäusl; Michael Roden
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

6.  Effect of lifestyle changes on whole-body protein turnover in obese adolescents.

Authors:  P Balagopal; E Bayne; B Sager; L Russell; N Patton; D George
Journal:  Int J Obes Relat Metab Disord       Date:  2003-10

7.  Glucagon-stimulating activity of 20 amino acids in dogs.

Authors:  D M Rocha; G R Faloona; R H Unger
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

Review 8.  Insulin resistance syndrome in children.

Authors:  Svetlana Ten; Noel Maclaren
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

Review 9.  Interplay between lipids and branched-chain amino acids in development of insulin resistance.

Authors:  Christopher B Newgard
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

10.  Amino acid balance across tissues of the forearm in postabsorptive man. Effects of insulin at two dose levels.

Authors:  T Pozefsky; P Felig; J D Tobin; J S Soeldner; G F Cahill
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

View more
  172 in total

1.  Habitual physical activity and plasma metabolomic patterns distinguish individuals with low vs. high weight loss during controlled energy restriction.

Authors:  Brian D Piccolo; Nancy L Keim; Oliver Fiehn; Sean H Adams; Marta D Van Loan; John W Newman
Journal:  J Nutr       Date:  2015-01-28       Impact factor: 4.798

2.  Association of branched and aromatic amino acids levels with metabolic syndrome and impaired fasting glucose in hypertensive patients.

Authors:  Liming Weng; Eoin Quinlivan; Yan Gong; Amber L Beitelshees; Mohamed H Shahin; Stephen T Turner; Arlene B Chapman; John G Gums; Julie A Johnson; Reginald F Frye; Timothy J Garrett; Rhonda M Cooper-DeHoff
Journal:  Metab Syndr Relat Disord       Date:  2015-02-09       Impact factor: 1.894

3.  Cord Blood Metabolites Associated with Newborn Adiposity and Hyperinsulinemia.

Authors:  Rachel Kadakia; Denise M Scholtens; Gerald W Rouleau; Octavious Talbot; Olga R Ilkayeva; Tabitha George; Jami L Josefson
Journal:  J Pediatr       Date:  2018-09-10       Impact factor: 4.406

Review 4.  Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?

Authors:  Antonio Sircana; Luciana Framarin; Nicola Leone; Mara Berrutti; Francesca Castellino; Renato Parente; Franco De Michieli; Elena Paschetta; Giovanni Musso
Journal:  Curr Diab Rep       Date:  2018-09-13       Impact factor: 4.810

5.  Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization.

Authors:  Sayanti Bhattacharya; Christopher B Granger; Damian Craig; Carol Haynes; James Bain; Robert D Stevens; Elizabeth R Hauser; Christopher B Newgard; William E Kraus; L Kristin Newby; Svati H Shah
Journal:  Atherosclerosis       Date:  2013-11-12       Impact factor: 5.162

6.  Gene expression profile of subcutaneous adipose tissue in BMI-discordant monozygotic twin pairs unravels molecular and clinical changes associated with sub-types of obesity.

Authors:  M Muniandy; S Heinonen; H Yki-Järvinen; A Hakkarainen; J Lundbom; N Lundbom; J Kaprio; A Rissanen; M Ollikainen; K H Pietiläinen
Journal:  Int J Obes (Lond)       Date:  2017-04-25       Impact factor: 5.095

Review 7.  Metabolomics and Metabolic Diseases: Where Do We Stand?

Authors:  Christopher B Newgard
Journal:  Cell Metab       Date:  2016-10-27       Impact factor: 27.287

8.  Inflammation and ER stress regulate branched-chain amino acid uptake and metabolism in adipocytes.

Authors:  Joel S Burrill; Eric K Long; Brian Reilly; Yingfeng Deng; Ian M Armitage; Philipp E Scherer; David A Bernlohr
Journal:  Mol Endocrinol       Date:  2015-01-30

Review 9.  Insulin resistance and the metabolism of branched-chain amino acids.

Authors:  Jingyi Lu; Guoxiang Xie; Weiping Jia; Wei Jia
Journal:  Front Med       Date:  2013-02-06       Impact factor: 4.592

10.  Metabolic changes in serum metabolome in response to a meal.

Authors:  Aahana Shrestha; Elisabeth Müllner; Kaisa Poutanen; Hannu Mykkänen; Ali A Moazzami
Journal:  Eur J Nutr       Date:  2015-12-10       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.